← Back to All Filings
United Therapeutics CEO Exercises Options & Sells $5.08M Under 10b5-1 Plan
UNITED THERAPEUTICS Corp
$UTHR4CIK: 0001082554
Subscribe to track UTHR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
🚨 INSIDER TRANSACTION ALERT
Company: United Therapeutics Corp (UTHR)
Insider: Martine A. Rothblatt (Chairperson & CEO)
Action: Option Exercise & Sale (10b5-1 Plan)
Date: 2026-10-08
Shares Sold: 9,500 @ avg ~$534.31
Gross Proceeds: ~$5.08M
Post-Transaction Direct/Trust Shares: 324,443 (Trust) + 40,513 (Direct) + 303,772 (Other Trusts/Spouse)
Comprehensive Analysis
Executive Summary
On October 8, 2026, Dr. Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp ($UTHR), executed an option exercise and sale covering 9,500 shares of Common Stock pursuant to a pre-established Rule 10b5-1 trading plan.
Transaction Details
- Option Exercise: Exercised 9,500 stock options with an exercise price of $117.76 per share (expiring March 15, 2027).
- Share Sales: Sold the 9,500 acquired shares across multiple tranches at weighted average prices between $525.50 and $541.23, generating total gross proceeds of approximately $5.08 million (~$534.31 per share volume-weighted average).
- Plan Context: The transactions were conducted in accordance with a Rule 10b5-1 trading plan adopted on November 7, 2025.
Ownership Impact
- Following these transactions, Dr. Rothblatt continues to hold 324,443 shares indirectly via the primary trust, 40,513 shares directly, and over 303,000 shares across additional family trusts and spouse holdings, alongside substantial remaining vested stock options.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.